Type 2 diabetes mellitus (T2DM) is a metabolic disease characterized by fasting and postprandial hyperglycemia and is due to a progressive deficit of insulin secretion that is initiated after a process of insulin resistance [1]; it affects 415 million people worldwide [2]. This evidence concerns the gene INS and Hyperglycemia.